2025-08-28 23:15:58
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Metropolis Healthcare consolidated Q3FY22 PAT at Rs. 41.03 crores
Posted On : 2022-02-12 13:33:25( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 295.6628 crores during the period ended December 31, 2021 as compared to Rs. 308.1924 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 41.0388 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 58.2665 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 7.98 for the period ended December 31, 2021 as compared to Rs. 11.34 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 295.6628 crs | ₹308.1924 crs |  -4.07% |
| Net Profit | ₹41.0388 crs | ₹58.2665 crs | -29.57% |
| EPS | ₹7.98 | ₹11.34 | -29.63% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 295.6628 crores during the period ended December 31, 2021 as compared to Rs.278.5184 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.41.0388 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.58.5694 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.7.98 for the period ended December 31, 2021 as compared to Rs.11.46 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 295.6628 crs | ₹278.5184 crs |  6.16% |
| Net Profit | ₹41.0388 crs | ₹58.5694 crs | -29.93% |
| EPS | ₹7.98 | ₹11.46 | -30.37% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.934.3828 crores during the 9 Months period ended December 31, 2021 as compared to Rs.716.2360 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.174.1953 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.121.7487 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.33.88 for the 9 Months period ended December 31, 2021 as compared to Rs.23.83 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹934.3828 crs | ₹716.2360 crs | 30.46% |
| Net Profit | ₹174.1953 crs | ₹121.7487 crs | 43.08% |
| EPS | ₹33.88 | ₹23.83 | 42.17% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 2419.95 as compared to the previous close of Rs. 2459.95. The total number of shares traded during the day was 6625 in over 1370 trades.
The stock hit an intraday high of Rs. 2442.45 and intraday low of 2363.10. The net turnover during the day was Rs. 15861011.00.
